NEW YORK (360DX) – Biomarker-based diagnostics firm Kypha announced it has acquired diagnostics platform and contract development company Biosensia.

Biosensisa will operate as a wholly owned subsidiary of Kypha. Further financial and other terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.